Registration for a live webinar on 'Innovative Vaccines and Viral Pathogenesis: Insights from Recent Monkeypox Research' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Introduction to Protein Structure and Function
-
1. Nature’s strategies in the regulation of enzyme activity by modifiers
- Prof. Antonio Baici
- Creation of Protein Variability by Manipulation of Genes
-
3. Perspectives on biological catalysis
- Prof. Stephen Benkovic
-
4. Fundamentals and principles for engineering proteolytic activity
- Prof. Charles Craik
- Metabolic Diseases Caused by Genetic Mutation
-
5. Modifications of pyruvate handling in health and disease
- Prof. Mary Sugden
-
6. Mitochondrial fatty acid oxidation deficiencies
- Prof. Niels Gregersen
-
7. Inborn errors of ketone body metabolism
- Prof. Toshiyuki Fukao
-
8. Cathepsin K in bone and joint diseases
- Prof. Dieter Bromme
-
9. Fabry disease: alfa-galactosidase A deficiency and enzyme replacement therapy
- Prof. David Warnock
-
10. Acid beta-glucosidase/glucocerebrosidase (GCase)
- Prof. Gregory Grabowski
-
11. GM2 gangliosidosis future treatments 1
- Prof. Brian Mark
-
12. GM2 gangliosidosis future treatments 2
- Prof. Brian Mark
-
13. The neuronal ceroid lipofuscinoses
- Prof. Sandra Hofmann
- Disorders of Blood Coagulation
-
14. Advances in fibrinolysis
- Dr. Paul Kim
-
16. Structure of thrombin, a Janus-headed proteinase
- Prof. Wolfram Bode
-
18. Fibrinogen and factor XIII
- Prof. John Weisel
-
19. Factor VIII and haemophilia A
- Dr. Geoffrey Kemball-Cook
-
20. Factor IX
- Prof. Bruce Furie
-
21. The biology and pathobiology of von Willebrand factor
- Prof. David Lillicrap
-
22. Thrombotic thrombocytopenic purpura
- Prof. J. Evan Sadler
-
23. Fibrinolysis
- Prof. Edward Tuddenham
- Other Molecular and Metabolic Disorders
-
24. Glucose-6-phosphate dehydrogenase deficiency
- Dr. Jane Leopold
-
25. Cytochrome b5 reductase deficiency and hereditary methemoglobinemia
- Dr. Scott Reading
-
26. Sickle cell disease
- Prof. Martin H. Steinberg
-
27. Pyruvate kinase deficiency
- Prof. Alberto Zanella
-
28. Heritable disorders of collagen
- Dr. Heather Yeowell
-
29. Duchenne muscular dystrophy
- Prof. Jeff Chamberlain
- Archived Lectures *These may not cover the latest advances in the field
-
30. Protein crystallography
- Prof. Michael James
-
31. Regulation of blood coagulation by the serpin, antithrombin
- Prof. Steve Olson
-
32. Rhodopsin and retinitis pigmentosa
- Dr. Shalesh Kaushal
-
33. The physiology and pathology of coagulation factor XI
- Dr. David Gailani
-
34. Cytochrome b5 reductase deficiency and hereditary methemoglobinemia
- Prof. Josef Prchal
-
35. Metachromatic leukodystrophy
- Prof. Volkmar Gieselmann
-
36. Serpins and serpinopathies
- Dr. James Whisstock
-
38. Pleiotropic and epistatic genes in sickle cell anaemia
- Prof. Ronald Nagel
-
39. Genetic disorders of carbonic anhydrases II and IV
- Prof. William Sly
-
40. GM2 gangliosidoses
- Prof. Don Mahuran
-
41. Kinetic analysis of protein activity
- Prof. Antonio Baici
Printable Handouts
Navigable Slide Index
- Introduction
- Table of contents
- Ketone body metabolism and its regulation
- Ketone bodies (1)
- Ketone bodies (2)
- Ketone bodies (3)
- Ketone body metabolism
- Regulation of ketogenesis
- Regulation of ketone body utilization
- Ketogenesis in different physiological conditions
- Diagnostic approach
- Ketosis and ketoacidosis
- Evaluation of ketone body metabolism
- Blood TKB levels as a function of fasting time
- Example (1)
- Example (2)
- Defects in ketogenesis (1)
- Defects in ketogenesis (2)
- Mitochondrial HMG-CoA synthase deficiency (1)
- Mitochondrial HMG-CoA synthase deficiency (2)
- HMG-CoA lyase deficiency
- HMG-CoA lyase deficiency in Japan
- Management for defects in ketogenesis
- Defects in ketone body utilization (ketolysis)
- 2 major disorders affecting ketone body utilization
- SCOT deficiency
- SCOT-deficient patients
- Japanese SCOT-deficient patients
- FFA and TKB levels before and after a meal
- TKB levels during GS08 fasting tests
- Monocarboxylate transporter 1 (MCT1)
- Monocarboxylate transporter 1 deficiency
- Mitochondrial AA-CoA thiolase (T2) deficiency
- T2 deficiency overview
- Metabolic pathway affected in T2 deficiency
- T2-deficient patients
- Molecular cloning of human T2 cDNA and gene
- T2 gene mutations in Vietnamese population
- 85 T2 gene mutations
- 85 T2 gene mutations (splice site mutations)
- Management for defects in ketone body utilization
- T2-deficient patients with “mild” mutations
- Definition of patients with “mild” mutations
- Japanese T2-deficient patients
- Urinary organic acid profiles at good condition
- Acylcarnitine analysis using blood spots
- Patients with “mild” vs. “severe” mutations
- Characterizing mutations in T2-deficient patients
- Patients and mutations (table)
- Phenotypes of mutant proteins
- Strategy for characterizing T2 mutants
- E252del enzyme assay
- Temperature-sensitive instability
- Heat instability test for enzyme activity (E252del)
- Kinetic analysis (E252del): CoA
- E252del effect on enzyme structure
- Effects of amino acid substitutions on the molecule
- Acknowledgements (1)
- Acknowledgements (2)
- Acknowledgements (3)
Topics Covered
- Ketone body metabolism
- Diagnostic approach
- Defects in ketogenesis
- Defects in ketone body utilization (succinyl-CoA:3-ketoacid CoA transferase deficiency, mitochondrial acetoacetyl-CoA thiolase deficiency)
- Molecular basis of mitochondrial acetoacetyl-CoA thiolase deficiency (protein and DNA levels)
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Fukao, T. (2016, July 27). Inborn errors of ketone body metabolism [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved October 31, 2024, from https://doi.org/10.69645/DHSQ6099.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Toshiyuki Fukao has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
A selection of talks on Biochemistry
Transcript
Please wait while the transcript is being prepared...
0:00
Let me introduce myself.
My name is Toshiyuki Fukao,
a Japanese pediatrician.
In this presentation, I would
like to talk about inborn
errors of ketone body metabolism.
0:14
Let me start my talk with ketone
body metabolism and its regulation.
Then move to the diagnostic approach
and defects in ketogenesis.
And finally, defects in
ketone body utilization.
The last half of my talk will focus
on the prenatal and molecular aspects
of mitochondrial acetoacetyl-CoA
thiolase (T2) deficiency.
0:41
The first topic is ketone body
metabolism and its regulation.
0:48
The term "ketone bodies"
refers to three
molecules: 3-hydroxybutyrate,
acetoacetate, and acetone.
3-hydroxybutyrate and
acetoacetate are ketone bodies
which are metabolically active.
They are small organic acids
with a molecular weight of about 100.
Acetone is volatile and responsible
for the ketone odor or breath
during ketoacidosis, but
metabolically it is not important.
1:21
Ketone bodies are acids, so an
accumulation of ketone bodies
results in ketoacidosis.
1:31
However, ketone bodies
are important vectors
of energy transfer from the
liver to the extrahepatic tissues.
Ketone bodies are especially
important in a shortage
of glucose-supply.